Nepal Approves AstraZeneca Covid Vaccine For Emergency Use
World News | Reuters | Friday January 15, 2021
Nepal on Friday granted approval for AstraZeneca's COVISHIELD vaccine against the coronavirus, the government said, following a meeting with neighbouring India, a major manufacturer of the shot.
AstraZeneca-Oxford Covid Vaccine Cleared By UK As It Fights Mutant Virus
World News | Reuters | Wednesday December 30, 2020
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
India Speeding Up Review Of Pfizer, AstraZeneca Covid Vaccines: Government Official
India News | Reuters | Monday December 7, 2020
India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world's second-most affected country struggles to contain the outbreak.
Serum Institute Sees AstraZeneca Covid Vaccine As "Very Good" Candidate
India News | Reuters | Saturday November 28, 2020
Serum Institute of India, the world's largest vaccine producer, sees AstraZeneca Plc's COVID-19 vaccine candidate as a "very good" option, giving it a major vote of confidence after some experts raised questions around its trial data.
Oxford Vaccine's Counter To Mounting Criticism: A New Global Trial
World News | Suzi Ring and James Paton, Bloomberg | Thursday November 26, 2020
AstraZeneca Plc's Covid-19 vaccine looks like it's headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study.
When And How Will COVID-19 Vaccines Become Available Around The World
World News | Reuters | Wednesday November 25, 2020
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95 per cent effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90 per cent effective.
Oxford Vaccine Can Be 90% Effective; Serum Institute Is India Partner
World News | Reuters | Monday November 23, 2020
AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world another weapon to fight the global pandemic and potentially cheaper to make, easier to distribute and faster to scale-up than rivals. The combined analysis from both dosing regimens resulted in an average efficacy of 70%.
Produced 40 Million Doses Of AstraZeneca Covid Vaccine: Serum Institute
India News | Reuters | Thursday November 12, 2020
Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's rival shot, as they both seek regulatory approval.
AstraZeneca COVID-19 Vaccine Trial Volunteer Dies, Says Brazil
World News | Reuters | Wednesday October 21, 2020
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.
Britain's Spies Defending COVID-19 Vaccine Work, MI5 Chief Says
World News | Reuters | Thursday October 15, 2020
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
World News | Agence France-Presse | Saturday September 12, 2020
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
India News | Reported by Sukirti Dwivedi, Edited by Swati Bhasin | Saturday September 12, 2020
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.
Trials Of Oxford Vaccine "Paused" After Unexpected Illness In Volunteer
World News | Agence France-Presse | Wednesday September 9, 2020
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
Wockhardt Shares Hit Upper Limit For Second Straight Day On COVID-19 Vaccine Supply To UK
Business | Edited by Abhik Deb (with inputs from agencies) | Tuesday August 4, 2020
On Monday, Wockhardt entered into a fill-and-finish agreement with the UK government to supply COVID-19 vaccines
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
World News | Reuters | Tuesday July 21, 2020
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
Nepal Approves AstraZeneca Covid Vaccine For Emergency Use
World News | Reuters | Friday January 15, 2021
Nepal on Friday granted approval for AstraZeneca's COVISHIELD vaccine against the coronavirus, the government said, following a meeting with neighbouring India, a major manufacturer of the shot.
AstraZeneca-Oxford Covid Vaccine Cleared By UK As It Fights Mutant Virus
World News | Reuters | Wednesday December 30, 2020
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
India Speeding Up Review Of Pfizer, AstraZeneca Covid Vaccines: Government Official
India News | Reuters | Monday December 7, 2020
India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world's second-most affected country struggles to contain the outbreak.
Serum Institute Sees AstraZeneca Covid Vaccine As "Very Good" Candidate
India News | Reuters | Saturday November 28, 2020
Serum Institute of India, the world's largest vaccine producer, sees AstraZeneca Plc's COVID-19 vaccine candidate as a "very good" option, giving it a major vote of confidence after some experts raised questions around its trial data.
Oxford Vaccine's Counter To Mounting Criticism: A New Global Trial
World News | Suzi Ring and James Paton, Bloomberg | Thursday November 26, 2020
AstraZeneca Plc's Covid-19 vaccine looks like it's headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study.
When And How Will COVID-19 Vaccines Become Available Around The World
World News | Reuters | Wednesday November 25, 2020
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95 per cent effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90 per cent effective.
Oxford Vaccine Can Be 90% Effective; Serum Institute Is India Partner
World News | Reuters | Monday November 23, 2020
AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world another weapon to fight the global pandemic and potentially cheaper to make, easier to distribute and faster to scale-up than rivals. The combined analysis from both dosing regimens resulted in an average efficacy of 70%.
Produced 40 Million Doses Of AstraZeneca Covid Vaccine: Serum Institute
India News | Reuters | Thursday November 12, 2020
Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's rival shot, as they both seek regulatory approval.
AstraZeneca COVID-19 Vaccine Trial Volunteer Dies, Says Brazil
World News | Reuters | Wednesday October 21, 2020
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.
Britain's Spies Defending COVID-19 Vaccine Work, MI5 Chief Says
World News | Reuters | Thursday October 15, 2020
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
World News | Agence France-Presse | Saturday September 12, 2020
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
India News | Reported by Sukirti Dwivedi, Edited by Swati Bhasin | Saturday September 12, 2020
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.
Trials Of Oxford Vaccine "Paused" After Unexpected Illness In Volunteer
World News | Agence France-Presse | Wednesday September 9, 2020
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
Wockhardt Shares Hit Upper Limit For Second Straight Day On COVID-19 Vaccine Supply To UK
Business | Edited by Abhik Deb (with inputs from agencies) | Tuesday August 4, 2020
On Monday, Wockhardt entered into a fill-and-finish agreement with the UK government to supply COVID-19 vaccines
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
World News | Reuters | Tuesday July 21, 2020
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
................................ Advertisement ................................
................................ Advertisement ................................
